Trial · NCT00362232
Adverse events464
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 464
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 57 | 1,526 | |
| other | Anaemia | Blood and lymphatic system disorders | Enoxaparin 30 mg Twice a Day (Bid) | 51 | 1,508 | |
| other | Thrombocythaemia | Blood and lymphatic system disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 33 | 1,526 | |
| other | Thrombocythaemia | Blood and lymphatic system disorders | Enoxaparin 30 mg Twice a Day (Bid) | 35 | 1,508 | |
| other | Bradycardia | Cardiac disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 15 | 1,526 | |
| other | Bradycardia | Cardiac disorders | Enoxaparin 30 mg Twice a Day (Bid) | 16 | 1,508 | |
| other | Tachycardia | Cardiac disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 96 | 1,526 | |
| other | Tachycardia | Cardiac disorders | Enoxaparin 30 mg Twice a Day (Bid) | 95 | 1,508 | |
| other | Abdominal pain | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 21 | 1,526 | |
| other | Abdominal pain | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 13 | 1,508 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 16 | 1,526 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 16 | 1,508 | |
| other | Constipation | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 258 | 1,526 | |
| other | Constipation | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 266 | 1,508 | |
| other | Diarrhoea | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 61 | 1,526 | |
| other | Diarrhoea | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 55 | 1,508 | |
| other | Dyspepsia | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 42 | 1,526 | |
| other | Dyspepsia | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 46 | 1,508 | |
| other | Hyperchlorhydria | Gastrointestinal disorders | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 9 | 1,526 | |
| other | Hyperchlorhydria | Gastrointestinal disorders | Enoxaparin 30 mg Twice a Day (Bid) | 17 | 1,508 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00362232/events